U.S. markets open in 8 hours 43 minutes

Adagio Therapeutics, Inc. (ADGI)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
56.08+0.78 (+1.41%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Slow Stochastic

Slow Stochastic

Previous Close55.30
Open55.01
Bid0.00 x 800
Ask0.00 x 1200
Day's Range50.34 - 56.08
52 Week Range20.50 - 58.59
Volume447,264
Avg. Volume728,103
Market Cap6.239B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-31.03
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Adagio Therapeutics, Inc.
    ARWR: Lowering target price to $66.00ARROWHEAD PHARMACEUTICALS IN has an Investment Rating of HOLD; a target price of $66.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more